The Lyme disease community was built, in large part, by people willing to question authority. That history makes the possibility of a Lyme disease echo chamber particularly uncomfortable to discuss. Patients challenged physicians who dismissed symptoms that did not fit established diagnostic categories. Advocates questioned testing standards they believed were inadequate, while researchers pushed against assumptions about diagnosis, treatment, persistence, and coinfections. That willingness to challenge prevailing ideas has often been one of the community’s greatest strengths. It forced difficult conversations and created space for patients who felt abandoned by conventional medicine.
But skepticism only has value when we apply it consistently. A community that demands scrutiny of government agencies, professional societies, insurance companies, and academic medicine should also scrutinize its own physicians, researchers, laboratories, advocacy organizations, websites, podcasts, and influential personalities. We cannot insist that outside institutions tolerate uncomfortable questions while treating the same questions differently when they point inward. Skepticism stops functioning as a method when it depends on who receives it.
